Roland B Walter Selected Research

Residual Neoplasm

1/2018	Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party.
1/2018	Minimal Residual Disease Testing After Induction Chemotherapy for Acute Myeloid Leukemia: Moving Beyond Prognostication?
1/2017	Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis.
3/2016	Should acute myeloid leukemia patients with actionable targets be offered investigational treatment after failing one cycle of standard induction therapy?
2/2016	Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?
7/2015	Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
4/2015	Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
4/2015	Minimal residual disease-directed therapy in acute myeloid leukemia.
2/2015	Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.
9/2013	Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roland B Walter Research Topics

Disease

133	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 05/2003
40	Neoplasms (Cancer) 05/2024 - 11/2005
20	Leukemia 02/2023 - 09/2003
13	Residual Neoplasm 01/2018 - 06/2010
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2023 - 06/2011
8	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 04/2010
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 08/2013
4	Infections 01/2023 - 04/2014
4	Cytopenia 01/2019 - 07/2014
4	Bites and Stings (Sting) 01/2018 - 01/2014
3	Neutropenia 01/2020 - 08/2013
2	Invasive Fungal Infections 07/2023 - 01/2021
2	Lymphoma (Lymphomas) 01/2019 - 08/2013
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2017 - 03/2003
2	Acute Promyelocytic Leukemia 01/2016 - 06/2012
2	Ovarian Neoplasms (Ovarian Cancer) 10/2014 - 10/2002
2	Breast Neoplasms (Breast Cancer) 01/2014 - 11/2005
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2013 - 01/2008
2	Atherosclerosis 01/2008 - 10/2003
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2023
1	Body Weight (Weight, Body) 12/2022
1	Weight Loss (Weight Reduction) 12/2022
1	Bacteremia 01/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Cytokine Release Syndrome 11/2021
1	Bone Marrow Failure Disorders 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2020
1	Multiple Myeloma 11/2020
1	Mucositis 01/2020
1	Febrile Neutropenia 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Fever (Fevers) 01/2020
1	Fatigue 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Hypophosphatemia 01/2020

Drug/Important Bio-Agent (IBA)

24	Gemtuzumab (Mylotarg)FDA Link 06/2022 - 08/2003
17	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 08/2003
10	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 04/2015
9	AntigensIBA 01/2022 - 01/2015
8	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2023 - 11/2013
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 04/2014
6	Cladribine FDA LinkGeneric 01/2023 - 11/2018
5	AntibodiesIBA 12/2023 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2003
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2013
4	Bispecific AntibodiesIBA 01/2019 - 07/2014
4	VitaminsIBA 12/2013 - 06/2011
3	AMG 330IBA 05/2024 - 01/2014
3	Chimeric Antigen ReceptorsIBA 12/2020 - 07/2014
3	Monoclonal AntibodiesIBA 01/2019 - 01/2011
3	Vorinostat FDA Link 05/2014 - 05/2012
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014 - 11/2005
2	CPX-351IBA 02/2024 - 01/2018
2	AstatineIBA 07/2023 - 01/2022
2	AnthracyclinesIBA 01/2023 - 11/2018
2	Azacitidine (5 Azacytidine)FDA Link 01/2023 - 01/2014
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2022 - 11/2020
2	venetoclaxIBA 11/2020 - 01/2019
2	Differentiation AntigensIBA 01/2018 - 07/2014
2	MEF2 Transcription FactorsIBA 11/2016 - 10/2015
2	Clofarabine (Clolar)FDA Link 08/2015 - 04/2015
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2014 - 06/2011
2	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2014 - 11/2005
2	Adenosine Triphosphate (ATP)IBA 01/2014 - 11/2005
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2013 - 11/2005
2	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2011 - 06/2011
2	NeopterinIBA 01/2008 - 10/2003
2	Scavenger Receptors (Scavenger Receptor)IBA 02/2006 - 05/2003
1	Sorafenib (BAY 43-9006)FDA Link 12/2023
1	NivolumabIBA 01/2023
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2022
1	Serum AlbuminIBA 12/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	posaconazole FDA Link 01/2022
1	Fluconazole (Zonal)FDA LinkGeneric 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021
1	tocilizumab (atlizumab)FDA Link 11/2021
1	insulin receptor-related receptor (IRR)IBA 11/2021
1	CalicheamicinsIBA 12/2020
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 11/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020
1	Decitabine FDA Link 01/2020

Therapy/Procedure

54	Therapeutics 05/2024 - 08/2003
29	Drug Therapy (Chemotherapy) 02/2024 - 11/2005
26	Cell Transplantation 02/2024 - 03/2011
13	Induction Chemotherapy 05/2024 - 06/2011
12	Immunotherapy 02/2023 - 05/2008
4	Radioimmunotherapy 07/2023 - 04/2010
3	Ambulatory Care (Outpatient Care) 01/2021 - 01/2016
2	Hematopoietic Stem Cell Transplantation 12/2020 - 05/2014
2	Investigational Therapies (Experimental Therapy) 03/2016 - 05/2014
2	Transplantation 02/2016 - 08/2015
1	Autologous Transplantation 12/2023
1	Catheters 01/2022
1	Drug Tapering 11/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2020